Eckert & Ziegler
Update in progressEUZ.F (Frankfurt)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Eckert & Ziegler SE develops and sells isotope technology components for medical, scientific and industrial use worldwide, with Medical and Isotope Products segments. It offers iodine-125 prostate implants, ruthenium-106/iodine-125 eye applicators for choroidal melanoma, brachytherapy seeds, radiopharmaceuticals, radiochemistry and lab equipment, X-ray and therapeutic sources, GA-68 generators, hot cells, Tc-99m generators and calibration sources. Formerly Eckert & Ziegler Strahlen- und Medizintechnik AG, renamed in March 2024. Founded 1992, Berlin.
Company score
- Sentiment
- 0.31
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.01
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.24
- Governance
- 0.17
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.11
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.21
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketFrankfurt (FRA)
- LocationGermany
- CEODr. Harald Hasselmann
- Founded1992
- Employees1,105
- Websitewww.ezag.com
Identifiers
- ISINDE0005659700
- LEI391200EUDABLUKXCKG48